Search ARM

ammoth Biosciences is developing the next generation of CRISPR tools to enable a wide variety of applications from therapeutics to diagnostics. The Company has discovered a suite of CRISPR protein systems with unique feature sets that go beyond those of traditional ones such as Cas9. Our initial focus was decentralized diagnostics, with the aim to democratize disease detection by bringing accurate and affordable molecular testing directly to consumers. More recent we have expanded our focus to include gene editing, therapeutics, and other novel applications. The Company has secured and established a broad IP estate through exclusive licenses from UC-Berkeley and its own filings. Mammoth is based in San Francisco, and was co-founded by CRISPR pioneer, Jennifer Doudna, and led by principal founders Trevor Martin, Janice Chen, and Lucas Harrington.

Contact Mammoth Biosciences